glp-1 negative effects 6 Common Side of Taking Medication The promise and peril of

For those with IBS-C, careful management and personalization are key to avoiding increased discomfort

In a Phase 2a substudy published in Nature Medicine, retatrutide at the 12mg dose reduced liver fat by an average of 82.4% from baseline at 24 weeks

adults diagnosed with obesity and roughly 35 million with Type 2 diabetes, its no wonder the popularity of GLP-1 therapies has skyrocketed, with numerous endorsements labeling them as miracle drugs. However, both doctors and patients are encountering challenges related to medication access, adherence, and insurance barriers

Available at: (2016)

Nausea: 246% increased risk , Vomiting 325% increased risk , Diarrhea 137% increased risk , and Drug discontinuation due to these adverse events :161% increased risk